Search research articles
Contact Us
Filters
Showing results (91-100 of 135) with videos related to
Page
of 14
Sort By:
Advances in Therapy
|
December 14, 2022
Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting
Charles Lynde, Elisabeth Riedl, Julia-Tatjana Maul, et al.
Journal of the American Academy of Dermatology
|
September 25, 2016
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, et al.
American Journal of Clinical Dermatology
|
July 20, 2022
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis
Jonathan I Silverberg, David N Adam, Matthew Zirwas, et al.
Dermatology and Therapy
|
July 11, 2025
Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison
Sonja Ständer, Andreas Pinter, Firas G Hougeir, et al.
Dermatology and Therapy
|
December 29, 2025
A Response to "Letter to the Editor Regarding 'Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison'"
Sonja Ständer, Andreas Pinter, Firas G Hougeir, et al.
Rheumatology and Therapy
|
April 25, 2024
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative
Iris Verbinnen, Emilio Monte-Boquet, Detlev Parow, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 22, 2022
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30<sup>th</sup> EADV Congress 2021
Andreas Pinter, Linda Stein Gold, Adam Reich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 17, 2022
Generalisierte pustulöse Psoriasis: Überblick zum Status quo und Ergebnisse einer Diskussionsrunde
Kristian Reich, Matthias Augustin, Sascha Gerdes, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 8, 2022
Generalized pustular psoriasis: overview of the status quo and results of a panel discussion
Kristian Reich, Matthias Augustin, Sascha Gerdes, et al.
Journal of the American Academy of Dermatology
|
August 11, 2019
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study
Diamant Thaçi, Lluís Puig, Kristian Reich, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 135) with videos related to
Sort By:
Page
of 14
Advances in Therapy
|
December 14, 2022
Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting
Charles Lynde, Elisabeth Riedl, Julia-Tatjana Maul, et al.
Journal of the American Academy of Dermatology
|
September 25, 2016
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, et al.
American Journal of Clinical Dermatology
|
July 20, 2022
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis
Jonathan I Silverberg, David N Adam, Matthew Zirwas, et al.
Dermatology and Therapy
|
July 11, 2025
Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison
Sonja Ständer, Andreas Pinter, Firas G Hougeir, et al.
Dermatology and Therapy
|
December 29, 2025
A Response to "Letter to the Editor Regarding 'Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison'"
Sonja Ständer, Andreas Pinter, Firas G Hougeir, et al.
Rheumatology and Therapy
|
April 25, 2024
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative
Iris Verbinnen, Emilio Monte-Boquet, Detlev Parow, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 22, 2022
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30<sup>th</sup> EADV Congress 2021
Andreas Pinter, Linda Stein Gold, Adam Reich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 17, 2022
Generalisierte pustulöse Psoriasis: Überblick zum Status quo und Ergebnisse einer Diskussionsrunde
Kristian Reich, Matthias Augustin, Sascha Gerdes, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 8, 2022
Generalized pustular psoriasis: overview of the status quo and results of a panel discussion
Kristian Reich, Matthias Augustin, Sascha Gerdes, et al.
Journal of the American Academy of Dermatology
|
August 11, 2019
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study
Diamant Thaçi, Lluís Puig, Kristian Reich, et al.
Page
of 14